Market Capitalization (Millions $) |
1 |
Shares
Outstanding (Millions) |
21 |
Employees |
- |
Revenues (TTM) (Millions $) |
11 |
Net Income (TTM) (Millions $) |
-41 |
Cash Flow (TTM) (Millions $) |
-14 |
Capital Exp. (TTM) (Millions $) |
2 |
Jaguar Health Inc
Jaguar Health Inc is a pharmaceutical company that focuses on the development and commercialization of natural, plant-based medicines. The company primarily develops therapeutic products derived from the Croton lechleri tree. Its flagship product is Mytesi, an FDA-approved drug used for the symptomatic relief of noninfectious diarrhea in adults living with HIV/AIDS. Jaguar Health also explores potential uses of the Croton lechleri tree in the treatment of other conditions such as cancer and inflammatory bowel disease. The company aims to provide innovative and effective treatments for various diseases through its natural product pipeline.
Company Address: 200 Pine Street, Suite 400 San Francisco 94104 CA
Company Phone Number: 371-8300 Stock Exchange / Ticker: NASDAQ JAGX
JAGX is expected to report next financial results on March 23, 2024. |
|
|